Background/Aims: Adipose-derived stem cells (ASCs) belong to mesenchymal stem cells and may play a potential role as seeding cells in stem cell transplantation. To be able to exploit stem cells as therapeutic tool, their defects in some important cellular functions, such as low survival rate and cellular activity, should be considered. This is especially the case for stem cells that are intended for transplantation. Of note, stem cell responses to hormones should be considered since estrogen is known to play a critical role in stem cell behavior. However, different impacts of the estrogen receptor (ER) types α and β have not been fully determined in ASC function. In this study, we investigated effects of ERα and ERβ on ASC proliferation, migration, as well as in adipogenesis. Methods: ASCs obtained from mice were cultured with 100nM ERα or ERβ agonist PPT and DPN, respectively. The ERα and ERβ antagonist ICI 182,780 (100nM) was used as control. Results: Compared to ERβ, ERα appears more potent in improving ASC proliferation and migration. Investigation of adipogenesis revealed that ERβ played a significant role in suppressing ASC-mediated brown tissue adipogenesis which is in contrast to ERα. These results correlated with reduced mRNA expression of UCP-1, PGC-1α and PPAR-γ. Conclusions: ERα plays a more critical role in promoting ASC proliferation and migration while ERβ is more potent in suppressing ASC brown adipose tissue differentiation mediated by decreased UCP-1, PGC-1α and PPAR-γ expression.
Introduction
Adipose-derived stem cells (ASCs) are part of mesenchymal stem cells and capable to differentiate in vitro into various mesenchymal cell lineages including bone, cartilage, containing phosphate buffered saline (PBS, Sigma-Aldrich, St. Louis, MO, USA). Subsequently, tissue was minced, washed, and suspended in Hank's solution containing collagenase type II (Sigma-Aldrich, St. Louis, MO, USA). A 30-60 min digestion at 37℃ with agitation (150 rpm) was performed until a smooth and even consistency resulted. Thereafter, cells were isolated via centrifugation, filtered using a 70μm nylon mesh, incubated with erythrocyte lysis buffer (150 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA), refiltered using a 40 μm cell strainer, and resuspended in complete medium composed of DMEM supplemented with 10% fetal bovine serum (FBS) and 100U/ml penicillin/streptomycin (GibcoTM Invitrogen Corporation, Carlsbad, CA, USA). Cells were plated at 2.5 × 10 3 /cm 2 in 10cm dishes (Corning Incorporated Life Sciences, Lowell, MA, USA) and cultured for 3-6 days in a humidified 5% CO 2 incubator until 80% confluence. Hereafter, cells were split equally and transferred to a new dish; this culture was labeled as passage 1. This last cell culture step was repeated and named as passage 2. All cells used in our experiments were of passage 2.
ASC proliferation assay ASC cell number was determined using CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega Corporation, Madison, WI, USA). Cells were reseeded in 96-well plates at a density of 2 × 10 3 cells per well. After being cultured in DMEM medium overnight, cells were incubated with different concentrations of ERα/β agonists PPT and DPN (Tocris bioscience, Bristol, UK) and ERs antagonist ICI (ICI 182,780, Tocris bioscience, Bristol, UK), respectively, for 24 h. Vehicle concentrations were 0 nM, 50 nM, 100 nM, and 200 nM. After treatment, cells were subsequently treated with 20 μL Celltiter 96 solution for 4 h at 37℃ in a humidified 5% CO 2 incubator and absorbance measured at 490 nm by microplate reader (BioTek Synergy HT, Manor, Texas, USA).
Immunofluorescence
To evaluate expression of the proliferation marker Ki67 and both estrogen receptors, rabbit polyclonal antibodies raised against ERα, ERβ, and Ki67 (Santa Cruz, Dallas, Texas, USA) were used. Briefly, ASCs were cultured for 2-3 days until 80% confluence. Now, cell culture medium was replaced by DMEM containing 0.2% FBS and corresponding ERα/β agonists (100 nM PPT, 100 nM DPN) and ERs antagonist (100 nM ICI), respectively, and incubated for 72 h. Subsequently, cells were fixed with 4% paraformaldehyde for 20 min, permeabilized using 0.3% triton in PBS for 5 min and washed by PBS. Blocking was performed using 1% donkey serum in PBS for 30 min, followed by washing steps. Hereafter, cells were incubated with ERα, ERβ, and Ki67 antibodies, respectively, diluted 1:500 with 1% BSA in PBS at 4℃ overnight. After washing 3 times with PBS on a shaker for 10 min each, cells were labeled using goat anti-rabbit TRITC or FITC-conjugated antibody (1:1000 Life technologies, Eugene, OR, USA) for 1 h in the dark at room temperature. Negative controls were incubated using normal serum instead of primary antibody. Nuclear counterstaining was performed using DAPI (Roche, Basel, Switzerland). Expression of ERα, ERβ and Ki67 was examined using a fluorescence microscope (Nikon ECLIPSE Ti, Japan).
ASC characterization
To confirm the ASC-progenitor phenotype, flow cytometry was performed after 3 days following the protocol in the previous subsection. Briefly, after tissue digestion ASCs (8 × 10 4 ) were washed, resuspended in 1% BSA in PBS, and incubated with FITC-conjugated anti-CD29, APC-conjugated anti-CD31, FITCconjugated anti-CD44, FITC-conjugated anti-CD45, and PE-conjugated anti-CD90 (BD Bioscience, San Jose, CA,USA), respectively, for 1 h at 4°C. Corresponding isotype-matched antibodies were used as controls. FACS analysis was performed using an Accuri C6 cytometer (BD, Franklin Lakes, NJ, USA).
ASC migration assay
For determining the migration potential, transwell migration assays were performed using millicell cell culture inserts (Corning Incorporated Life Sciences, Lowell, MA, USA) with 8.0-μm pore polycarbonate membranes. Briefly, ASCs were seeded in transwell membrane plates at density of 2 × 10 4 cells per well. After 2 h, the ER agonists or antagonist (50 nM & 100 nM PPT, 50 nM & 100 nM DPN, 50 nM & 100 nM ICI, 50 nM & 100 nM ICI+PPT, 50 nM & 100 nM ICI+DPN) in DMEM medium containing 0.2% FBS were added to the lower site of trans-well membrane plates, and incubated for 12 h. Subsequently, migrated cells remaining in the trans-well membrane were fixed with ice-cold methanol for 20 min, stained using 10% crystal-violet (Sigma-Aldrich, St.Louis, MO, USA) for 30 min at room temperature, and counted by light microscopy.
In addition, kinetics of cell migration were measured using scratch migration assays. Briefly, ASCs were seeded in 6-well plates at a density of 2 × 10 5 cells per well (70-90% confluency). After 24 h, wounds were introduced using a 200 μl pipette tip. 12 h after wounding, cell migration was determined by microscopy (Olympus, Shinjuku, Tokyo, Japan). For evaluation of ASC migration, pictures were taken nearly in the same position, and the horizontal distance between migrated cells and the initial wound was measured.
Adipose-derived stem cell differentiation to brown adipogenic tissue Adipogenic differentiation capacity of ASCs cultured with ERα and ERβ agonists or ERs inhibitor was determined as follows. Briefly, ASCs (5 × 10 4 cells per well) were cultured in DMEM containing 10% FBS and 1% (v/v) penicillin-streptomycin (10000 units/ml of penicillin, 10,000 μg/ml of streptomycin in 0.85% saline) at 37°C, in a humidified atmosphere and 5% CO 2 overnight. The next day, confluent ASCs were exposed to ER agonists PPT (100nM) and DPN (100nM) and ERs antagonist ICI, as well as single agonists in combination with ICI (100 nM ICI+PPT, 100 nM ICI+DPN) for 3 days, respectively. After stimulation, ASCs were cultured in brown adipose differentiation medium for 6 days. Medium was changed after 2 days to secondary differentiation medium (see below) and cells cultured for another 4 days. Hereafter, the medium was changed back to DMEM containing 10% FBS and 1% penicillin-streptomycin and cells cultured for another 2 days. Brown adipose differentiation medium was composed of 3-isobutyl-methylxanthine (0.5 mM; Sigma), dexamethasone (1 μM; Sigma-Aldrich, St. Louis, MO, USA), rosiglitazone (1 μM; Sigma-Aldrich, St. Louis, MO, USA) and insulin (15 μg/ml; Sigma-Aldrich, St. Louis, MO, USA) in DMEM plus 10% FBS and 1% penicillin-streptomycin. Secondary differentiation medium contained insulin (15 μg/ml; Sigma-Aldrich, St.Louis, MO, USA) in DMEM plus 10% FBS and 1% penicillin-streptomycin.
Oil-red O staining
Adipocyte-differentiated ASCs were stained using 0.35% red O dye as previously reported [22] . In brief, at day 8 of adipocyte differentiation, the cells were fixed with 70% ethanol, stained with Oil-Red (Guidechem, Shanghai, China) for 30min, and washed three times with PBS. All procedures were performed at room temperature. Red-stained lipid droplets were examined using an optical microscope.
Reverse transcription polymerase chain reaction (RT-PCR)
ERα, ERβ, and established brown adipocyte marker mRNAs were detected using reverse transcription (RT) PCR. Total RNA was isolated using Trizol (Life technologies Invitrogen, Eugene, OR, USA) according to manufacturer's instructions. In brief, 1ug of total RNA was reverse-transcribed using reverse transcription system (Promega Corporation, Madison, WI, USA). One tenth of resulting cDNA was used for further PCR amplification. PCR was performed at 95°C for 5 min, 95°C for 30 s, 55°C for 30 s, and 72°C for 4 min in 25 ul reaction mixtures. Number of cycles was 35. Targets were ERα, ERβ, UCP-1, PPAR-γ, PGC-1α, and GAPDH as housekeeping gene. Primer sequences are shown in Table 1 .
Statistical analysis
All values are expressed as mean ± SEM. Data were analyzed by performing T test using SPSS 15.0. A value of P < 0.05 was considered statistically significant. 
Results
ERα and ERβ are membrane-bound receptors that shuttle to the nucleus upon ligand binding, thus, functioning as ligand actived transcription factors processing pleiotropic effects [23] . Both receptors regulate different genes in different tissues [24] . It has been reported that ERs play a critical role in enhancing the osteogenic differentiation potential of ASCs [25] . Since only few informations are available about the effect of each ER in proliferation, migration, apoptosis, and adipogenesis of ASCs, we performed work to evaluate their actions in those settings using specific agonists and one specific antagonist.
ER agonists, especially PPT, improve mouse adipose-derived stem cell proliferation
To investigate whether ER stimulation has the ability to influence ASCs in a concentration dependent manner, concentration gradients and proliferation assays were performed (Fig.  1B) . As shown in Fig. 1C , 100 nM PPT significantly improves cell proliferation at day 3. This effect kept similar when compared to DPN stimulation (Mean ± SEM of PPT group:226.0 ± 17.74, N = 3, PPT vs DPN p = 0.0458). However, ASC proliferation was decreased by suppressing ERs binding to agonists and the inhibition was not reversible when 100 nM PPT and DPN were present in the 100 nM ICI medium (Fig. 1C) . Observed effects of ERs were concentration dependent (Fig. 1B) . These data suggest that, compared with ERβ, ERα may play a more effective role in estrogen-dependent proliferation of ASCs. Moreover, Ki67 expression was examined by immunofluorescence as an indication for proliferation (Fig. 1A) and showed higher proliferation in the PPT group. group: 293.0 ± 12.07, N = 3. PPT vs DMEM group p = 0.0035). Similarly, ASCs supplemented with 100 nM DPN left a similar blank but no statistical significance was observed when compared with DMEM group, as shown in Fig. 4B (Mean ± SEM of DPN group: 198.7 ± 11.67 N = 3. DPN vs DMEM group p = 0.8055). Additionally, transwell migration assays were also used for evaluating ASC migration (Fig. 5A) . Our results showed that ERα improved the migration of ASCs in comparison to DMEM group (Mean ± SEM of column 100 PPT group = 205.0 ± 5.132, N = 3. PPT vs DMEM group p = 0.0194). In contrast, ERβ did not improved the migrational ability of ASCs when compared to DMEM group (Fig. 5B) .
ERα induces but ERβ inhibits brown adipogenesis of ASCs
To determine whether ERβ affected the adipogenic differentiation of ASCs, we added 100nM ER agonists with or without ERs antagonist to brown adipogenic differentiation media. After 8 days, cells were stained with oil red O. The results show that ERβ strongly inhibits brown adipogenic differentiation (Fig. 6) . To further confirm adipogenic differentiation, we determined expression of differentiation markers by RT-PCR analysis. The brown adipogenesis-inducing influence of ERβ, as indicated by its agonist DPN, was indicated by downregulation of the differentiation markers UCP1, PGC-1α and PPAR-γ in comparison to control (Fig. 7B) . In contrast, ERα stimulation by its agonist PPT resulted in upregulated expression of these differentiation markers in comparison to control (Fig. 7B) . Addition of the inhibitor resulted in no detectable gene expression of UCP-1, PGC-1α, and PPARγ. The combination of each agonist with the antagonist resulted in low expression of PPARγ but none of the other two markers. Compared with control, PGC-1α, UCP-1 and PPARγ mRNA expression differed significantly (Fig. 7C, D, E) . Expression of UCP-1 mRNA in the 100nM PPT group and 100 nM DPN group indicated that ERα mainly induces brown adipogenesis and that ERβ inhibits this effect (Fig. 7C , Mean ± SEM of 100nM PPT group: 75.04 ± 10.56 N = 3. PPT vs DPN p = 0.0039; Mean ± SEM of 100 nM DPN group: 10.07 ± 2.314 N = 3. DPN vs DMEM p = 0.0021). PPARγ mRNA expression presented similar trends as UCP-1 mRNA expression (Fig. 7E) . Numerical evaluation of migrated cell numbers corresponding to (A). As can be seen, stimulating cells using 100 nM PPT results in improved migration when compared to control which is not the case when ASCs were stimulated using 100 nM DPN. Incubation using ICI alone or its combination with each agonist resulted in decreased migration when compared to control. Data represent means ± SEM (n = 3). * (**, ***) indicates P value < 0.05 (0.01, 0.001) as compared with DMEM. Photographs of the combinations of agonists and antagonist are not shown. 
Discussion
ERα and ERβ can be present in two forms, i.e. membrane-bound and nucleus-located. Both estrogen receptors mediate gene transcription in different manners and may also have different impacts dependent on cellular context. However, the role of ERs in proliferation, migration, survival, apoptosis and adipogenesis of ASCs remains unknown. In this study, we mainly focused on determining the effects of ERα and β on ASCs isolated from white adipose tissue of male mice. By in vitro preconditioning with ERα agonist PPT and ERβ agonist DPN, we showed that ERα and ERβ act as positive regulators improving ASC proliferation and migration. These beneficial effects are concentration dependent and can be inhibited by ER inhibitor ICI which targets both receptors. Compared with the function of PPT and DPN, ASCs seemed to be more sensitive to PPT, indicating that ERα plays a more critical role in mediating proliferation, wound healing and migration than ERβ. Same effects can be found in breast cancer cells through an interplay between AP-1 and ERα [26] . Of note, by using RT-PCR our study revealed that activation of ERβ in ASCs repressed brown adipogenesis by decreasing expression of UCP-1, PGC-1α, and PPAR-γ. In contrast, ERα induces UCP-1, PGC-1α, and PPAR-γ expression, and, thus, may improve brown adipogenesis. Although a former study showed similar effects of ERβ [27] , our work explains and compares the effect of ERα in more detail. Taken together, our results and that of Montales et al. concerning brown adipogenesis might be the basis to further investigate if this ERβ-mediated effect is usable as treatment option in obesity, i.e increasing BAT and consequently increasing cellular energy consumption. If these findings and approaches might develop positively and promising in the long-term, they may represent a supplementary, or even additional, option to current treatment.
Since MSCs were identified in bone marrow as multi-potent cells in 1968, their ability of self-renewal and multi-potency was explored by scientists [28] . MSCs derived from various tissues were identified and bone marrow-derived cells have been the most intense studied one regarding tissue repair and regeneration. BMSCs are known for their high differentiation potential and low morbidity during harvesting. In 2001, ASCs were first identified as MSCs from adipose tissue [29] and since then increasing studies indicated that ASCs might be suitable as seeding cells for tissue engineering and regenerative medicine [30] . ASCs and BMSCs share common characteristics, including growth and morphology [31] , displaying fibroblastic features, and a similar transcriptional and cell surface marker expression profile [32] . At present, much of the research is mainly focusing on the effects and mechanisms of estrogen and its receptors for improving BMSC behavior in tissue engineering applications [33] . Although an ideal cell type for transplantation due to availability of convenient methods and their presence in large cell quantities, ASCs still remain elusive with respect to effects mediated by estrogen receptor α and β. Like other MSCs, ASCs express the typical mesenchymal markers CD29 and CD90 [34] . In the present study, we demonstrated that activation of ERα and β results in no changes of the phenotypic features of ASCs. Furthermore, we observed that there is a close relationship between the activation of ERα and β in ASC proliferation and migration. ASCs activated by ERα agonist PPT showed significantly enhanced cell proliferation, migration and wound healing. On the other hand, ERβ agonist DPN seemed to be less efficient than PPT in stimulating ASC proliferation and migration. In line with our results, it has been reported that stem cells stimulated by estrogen show improved cell proliferation [35] . Therefore, we hypothesize that the main effects of estrogen in improving ASC proliferation, migration and adipogenesis is mediated by ERα. In contrast to this, it was published that estrogen level variation can hardly alter the capacity for stem cell proliferation [36] . Differences between results of Ng et al. and ours might result because different concentrations of estrogen were used for ASC-based experiments [36] . To evaluate our hypothesis of concentration dependency, concentration gradients were performed by us to identify the most suitable range of ER agonists. Effects were predominantly observed when the concentration of PPT and DPN was 100nM. Tests have also been performed to identify the most suitable concentration on Ki67 expression and cell migration which was also identified as 100nM in both settings. Our observed results that 100nM of each agonist is within the optimal range in in vitro settings might be explained by the number of ligands binding to their receptors, and resulting signal strength. Nevertheless, more studies should be performed to clarify possible mechanisms of these beneficial activities.
There are four signaling pathways of ERs, each pathway leading to different activities including inflammation, cardioprotection and neural plasticity [37] . Similar to BMSCs, ASCs have the property to differentiate into osteoblastic, chondrocytic, adipocytic and neurogenic cells [38] [39] [40] . The influence of estrogen on differentiation of ASCs has been demonstrated earlier but remains controversial [41, 42] . This may be based on the different origin of isolated cells and different setting researchers used, i.e. osteogenesis and adipogenesis. Thus, to obtain a clearer picture, more work has to be performed in each of the corresponding fields.
In recent published literature much attention has been paid to the role of cell transplantation in wound healing, plastic surgery and regenerative medicine [43] . What may give rise to great interest might be the potential use of ASC transplantation to treat obesity. Most obesity therapies are aimed at decreasing energy intake, while it seems conceivable that increasing cellular energy expenditure could be an useful approach to reduce obesity. Thus, adaptive thermogenesis induced by brown adipocyte differentiation of ASCs might be a great tool to increase energy expenditure. In view of this, efficient improvement of the differentiation rate of ASCs into brown adipocytes is needed. The present study selected white adipose tissue-derived stem cells (W-ASCs, ASCs) and demonstrated a positive effect of ERα and reverse effect of ERβ in influencing ASCs differentiating into brown adipose tissue. In addition, we found that the differentiation rate of ASCs upon DPN stimulation was significantly lower than in PPT and ICI groups. RT-PCR showed that expression of brown adipose tissue-specific markers UCP-1 and PGC-1α was lower in DPN group. The expression of adipose differentiation marker PPAR-γ showed similar trends, indicating that adipogenesis is inhibited by DPN. Thus, our results identified different effects of ERα and ERβ in BAT differentiation. This observation is supported by the assumption that PGC-1α is considered as an important regulator in BAT where it is regulating PPAR-γ action, and interaction of both proteins stimulates UCP-1 expression [44, 45] . Moreover, PGC-1α knockout mice are not susceptible to diet-induced obesity [46] . However, PPAR-γ is weakly expressed in our study in the DPN group but UCP-1 expression lost. This implies that other factors are also involved in BAT thermogenesis, which might be further supported by the observation that the combination of agonist and antagonist resulted in weak expression of PPAR-γ, but that PPAR-γ and UCP-1 expression was not detectable in the antagonist group. Detected expression and signaling of ERβ in BAT is contrary to Rodriguez-Cuenca et al. who did not detected ERβ1 and ERβ2 but in line with their results considering ERα [47] . This difference might be based on a different rodent species used (mice vs. rats). However, detailed gene expression analyses as well as molecular mechanism investigations under both estrogen receptor activation and inhibition are out of scope of this work. Consequently, those evaluations are needed to be addressed in future work and varying results addressed by use of different animal species. Recently, Shin et al. and Wang et al. showed that miR-137 and miR-342-3p regulate adipose tissue-derived mesenchymal stem cell differentiation and proliferation [48, 49] . Moreover, Petrov et al. reported that glycosaminoglycans are able to influence the balance of adipogenic/chondrogenic fate [50] . If such regulatory mechanisms are also present and/or could be exploited in our setting needs to be addressed in future studies.
Recently, a study suggested that white adipose progenitors lacking the ERα program will be forced to differentiate into smooth muscle and brown adipogenic cells. The underlying mechanism is probably based on TGFβ signaling which is involved in progenitor reprogramming downstream of the ERα signal pathway [51] . The authors' conclusion of that study has similarities with ours but differences still remain. Our study showed that ERα promotes brown adipogenesis, and that ERβ plays a significant key role in suppressing brown tissue adipogenesis. However, ICI-mediated inhibition of gene expression of both ERs resulted in comparable brown adipogenesis, compared with control group. Moreover, expression of BAT-specific markers showed similar results in our investigated settings. These observations indicate that other mechanisms/pathways might be involved. Thus, more studies are needed to investigate ERβ-mediated suppression of ASC-resulting BAT differentiation and the interrelationship between TGFβ and ERs.
In summary, we demonstrated that an optimal stimulation of both ERα and ERβ can effectively improve ASC proliferation, migration, and wound healing. However, the effect of ERβ alone is slightly weaker, suggesting marginally improved effects of simultaneous double stimulation. In addition, inhibition of ERs by ICI resulted in suppression of these aforementioned activities. Investigation of adipogenesis revealed that the ERα agonist showed similar effects as control group while ERβ stimulation played a significant role in suppressing ASC brown tissue adipogenesis via down-regulating UCP-1, PGC-1α, and PPAR-γ mRNA expression. In order to further develop estrogen and its receptors as modulators for ASC regulation, more work should be concentrated on the signaling pathways of ERs in ASCs. Moreover, in vivo studies are also needed to investigate and identify the mechanisms of ERdependent signaling pathways. Those studies should also provide deeper insights into ERmediated regulation of white adipose tissue-derived ASC adipogenesis in vitro. Zhang 
